Navigation Links
Relieving Pain for Diabetes Patients with Neuropathy
Date:12/10/2013

WALTHAM, Mass., Dec. 10, 2013 /PRNewswire/ -- Is there anything more frustrating than waking up in the middle of a nice dream? Awakening in the middle of the night can negatively affect one's mood the next day. It's one thing to be roused by an alarm clock or persistent pet that wants to be fed or walked, but being jolted out of sleep by agonizing leg pain is another story. Unfortunately, many of those who suffer from a condition called Painful Diabetic Neuropathy (PDN) are all too familiar with this occurrence.  

PDN affects many people with diabetes. They might experience burning, stabbing or shooting pains in the feet or legs, especially when trying to sleep. The pain is often so severe it either makes falling sleep impossible or wakes them up.

Luckily, a company called NeuroMetrix, Inc. has recognized the need for a treatment that will work while the patient sleeps. NeuroMetrix is a Waltham, MA-based medical device company that develops and markets tests and therapies for diabetic neuropathies. They have developed the SENSUS™ Pain Management System, an innovative new device to provide relief to those suffering from chronic diabetes pain. As Shai Gozani, President and CEO of NeuroMetrix, reports, "People often describe the pain to be like walking on a bed of nails or feeling like their feet are on fire. SENSUS may help relieve that pain."

One of the best parts about SENSUS is that it's lightweight and discreet. Wrapping around the patient's calf, it can be worn right under clothing. Its easy one-button control makes it the ideal solution for PDN sufferers of any age. It is non-addictive, non-narcotic, free of side effects and provides pain relief even during sleep. SENSUS is also the first transcutaneous electrical nerve stimulator cleared by the U.S. Food and Drug Administration to be used while sleeping. In addition to its pain relief benefits, should SENSUS become dislodged from the skin for any reason, it immediately shuts off.

For more information, visit www.SENSUSRx.com, who paid for the writing and dissemination of this release.

Contact:  Laura Radocaj, Dian Griesel Int'l.
212.825.3210

 


'/>"/>
SOURCE NeuroMetrix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. World Pain Relieving Drug Market 2013-2023
2. Lipitor Lawsuit News: As Lipitor Diabetes Lawsuits Move Forward, Bernstein Liebhard LLP Comments on JAMA Editorial Expressing Concern about the "Statinization" of U.S.
3. Synthetic Biologics Enters into License with Cedars-Sinai Medical Center to Develop Novel Anti-infective Approaches for Irritable Bowel Syndrome (IBS), Obesity and Diabetes
4. Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation
5. Surveyed Endocrinologists Consider Eli Lillys Dulaglutide To Have an Edge Over Competitors for the Treatment of Type 2 Diabetes Patients Who Are Inadequately Controlled On Metformin
6. PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022
7. Diabetes, Metabolic Syndrome and Cardiovascular Disease
8. How Some People with Diabetes Can Eliminate the Pain of a Daily Procedure
9. Tandem Diabetes Care Announces Closing of Initial Public Offering
10. Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Initial Public Offering of Common Stock
11. Bone-Breaking News: Mayo Clinic Solves Mysterious Link Between Diabetes and Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/5/2017)...  In response to the nationwide opioid epidemic, ... (AAOMS) released prescribing recommendations that urge ibuprofen – ... a first-line therapy to manage a patient,s acute ... Recognizing the value and importance of the ... Acute and Postoperative Pain Management" stresses that practitioners ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance ... greater Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to ... and deadly chromosome abnormality. , After struggling since birth with several health challenges, ...
(Date:10/13/2017)... Ky. (PRWEB) , ... October 13, 2017 , ... The ... MPH to become its next President and Chief Executive Officer, succeeding Dr. James C. ... CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
Breaking Medicine News(10 mins):